The impact of smoking and diabetes on homocysteine levels in patients with myocardial infarction

Abstract EN

The iaim of this study is to measure the compound Hcy levels as a risk factor for patients with MI to the number of patients in the province of Thi-Qar.

Increased levels of homocysteine in the blood is considered a risk factor for myocardial Infarction.

Smoking and diabetes disease lead to increased concentrations of homocysteine and thus increase the risk of MI.

Blood samples were obtained from (63) patients with myocardial infarction, as well as (48) healthy subjects as a control group.

The results indicated to that proportion of patients male (57%) and females (43%), smokers (49%) and non- smokers (51%), most of them are females.

The results also showed that (32%) live in cities, compared to (68%) live in rural areas, and patients who have a family history of (56%) compared to (44%) They do not have a family history and the results showed that diabetes disease is more associated with diseases of the disease infarction heart and by (86%), followed by hypertension (56%) disease.

Serum homocysteine was significantly higher in MI patients compared to the control group.Homocysteine levels were higher in low educated, smokers and unemployed individuals, less family income individuals as well as in individuals with family history of MI or Coronary artery disease.

High hypertensive, diabetic and obese individuals had also higher levels of homocysteine.

Based on the results of this study suggested measuring the amino acid Homocysteine levels of security as one of the effective ways to diagnose patients with myocardial infarction in hospitals.